Interpharma mobilizes patient advocacy to oppose Swiss drug price reduction legislation

The pharmaceutical industry association Interpharma is leveraging patient groups to lobby against parliamentary efforts to lower drug prices in Switzerland. This strategy marks an escalation in industry resistance as legislative deadlines approach, though the extent of patient participation remains unclear.